In the context of MS, BBB dysfunction is orchestrated by various mediators that can also activate TRPV4, which renders endothelial TRPV4 activation a putative candidate mechanism of BBB dysfunction in MS [45–48]. This evidence concerns the gene TRPV4 and myeloid sarcoma.